公开(公告)号：US07670985B2

公开(公告)日：2010-03-02

申请号：US11891263

申请日：2007-08-09

Applicant: Yunjie Ding ,  Hejun Zhu ,  Tao Wang ,  Guiping Jiao ,  Yuan Lv

Inventor： Yunjie Ding ,  Hejun Zhu ,  Tao Wang ,  Guiping Jiao ,  Yuan Lv

IPC: B01J21/18 ,  B01J27/06 ,  B01J23/00 ,  B01J23/02 ,  B01J23/06 ,  B01J23/40 ,  B01J23/74 ,  B01J23/10 ,  B01J23/32 ,  B01J23/58 ,  B01J23/56 ,  C01B31/00 ,  C01B31/02 ,  C09C1/56

CPC classification number: B01J23/75 ,  B01J21/18 ,  B01J23/76 ,  B01J23/78 ,  B01J23/83 ,  B01J23/8913 ,  B01J35/1028 ,  B01J35/1042 ,  B01J35/108 ,  B01J37/0201 ,  B01J37/0205 ,  B01J37/0207 ,  B01J37/18 ,  C07C29/156 ,  C10G2/332 ,  Y02P20/52 ,  C07C31/02 ,  C07C31/04

Abstract: The invention provides an activated carbon supported cobalt based catalyst for directly converting of synthesis gas to mixed linear alpha-alcohols and paraffins, comprising cobalt, an activated carbon carrier, a metal promoter which is at least one selected from the group consisting of a zirconium component, a lanthanum component, a cerium component, a chromium component, a vanadium component, a titanium component, a manganese component, a rhenium component, a potassium component, a ruthenium component, a magnesium component and a mixture thereof, wherein the cobalt and the promoter are deposited on the activated carbon carrier or substantially uniformly dispersed therein, and the metal promoter is present in the form of a metal, an oxide or a combination thereof.

Abstract translation: 本发明提供了一种用于将合成气直接转化成混合的线性α-醇和链烷烃的活性炭负载的钴基催化剂，其包括钴，活性炭载体，金属促进剂，其是选自锆组分 镧组分，铈组分，铬组分，钒组分，钛组分，锰组分，铼组分，钾组分，钌组分，镁组分及其混合物，其中钴和 助催化剂沉积在活性炭载体上或基本均匀地分散在其中，并且金属助催化剂以金属，氧化物或其组合的形式存在。

公开(公告)号：US07663433B2

公开(公告)日：2010-02-16

申请号：US12187402

申请日：2008-08-07

Applicant: Chun-Lung Hung ,  Wen-Ming Chen ,  Jie Liu ,  De-An Zhang ,  Wang-Chang Duan ,  Tao Wang

Inventor： Chun-Lung Hung ,  Wen-Ming Chen ,  Jie Liu ,  De-An Zhang ,  Wang-Chang Duan ,  Tao Wang

IPC: H03F1/14

CPC classification number: H03F3/183 ,  H03F1/305 ,  H03F2200/03

Abstract: An audio amplifier is provided. The audio amplifier includes an amplifier, a biasing circuit, and a time-delay circuit. The amplifier circuit is for amplifying audio signals. The biasing circuit is for providing a bias voltage to the amplifier circuit to actuate the amplifier circuit. The time-delay circuit is for receiving a pulse signal and delaying the bias voltage to avoid a sudden actuation of the amplifier circuit based on the pulse signal. The time-delay circuit comprises a first input for receiving the pulse signal, a first resistor coupled to the first input, a first output coupled to the biasing circuit, a first BJT whose base, emitter, collector are respectively coupled to the first resistor, ground, and the first output.

Abstract translation: 提供音频放大器。 音频放大器包括放大器，偏置电路和时间延迟电路。 放大器电路用于放大音频信号。 偏置电路用于向放大器电路提供偏置电压来致动放大器电路。 时间延迟电路用于接收脉冲信号并延迟偏置电压，以避免基于脉冲信号的放大器电路的突然致动。 时延电路包括用于接收脉冲信号的第一输入端，耦合到第一输入端的第一电阻器，耦合到偏置电路的第一输出端，​​其基极，发射极，集电极分别耦合到第一电阻器的第一BJT， 地面和第一输出。

公开(公告)号：US20090325985A1

公开(公告)日：2009-12-31

申请号：US12490727

申请日：2009-06-24

Applicant: Alicia Regueiro-Ren ,  Jacob Swidorski ,  Zheng Liu ,  Tao Wang ,  Zhongxing Zhang ,  Lawrence G. Hamann ,  Nicholas A. Meanwell ,  David J. Carini ,  Wenying Li

Inventor： Alicia Regueiro-Ren ,  Jacob Swidorski ,  Zheng Liu ,  Tao Wang ,  Zhongxing Zhang ,  Lawrence G. Hamann ,  Nicholas A. Meanwell ,  David J. Carini ,  Wenying Li

IPC: A61K31/519 ,  A61K31/44 ,  C07D471/04

CPC classification number: C07D471/04 ,  C07D519/00

Abstract: Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, diketopiperidine derivatives that possess unique antiviral activity are provided. These compounds are useful for the treatment of HIV and AIDS.

Abstract translation: 阐述了具有药物和生物影响特性的化合物，其药物组合物和使用方法。 特别提供具有独特抗病毒活性的二酮哌啶衍生物。 这些化合物可用于治疗艾滋病毒和艾滋病。

公开(公告)号：US20090285473A1

公开(公告)日：2009-11-19

申请号：US11961659

申请日：2007-12-20

Applicant: Jianguo Li ,  Tao Wang ,  Yimin Zhang

Inventor： Jianguo Li ,  Tao Wang ,  Yimin Zhang

IPC: G06K9/62

CPC classification number: G06K9/4619 ,  G06K9/6256

Abstract: Machine-readable media, methods, apparatus and system for obtaining and processing image features are described. In some embodiments, groups of training features derived from regions of training images may be trained to obtain a plurality of classifiers, each classifier corresponding to each group of training features. The plurality of classifiers may be used to classify groups of validation features derived from regions of validation images to obtain a plurality of weights, wherein each weight corresponds to each region of the validation images and indicates how important the each region of the validation images is. Then, a weight may be discarded from the plurality of weights based upon a certain criterion.

Abstract translation: 描述了用于获得和处理图像特征的机器可读介质，方法，装置和系统。 在一些实施例中，可以训练从训练图像的区域导出的训练特征的组以获得多个分类器，每个分类器对应于每组训练特征。 多个分类器可以用于对从验证图像的区域导出的验证特征的组进行分类以获得多个权重，其中每个权重对应于验证图像的每个区域，并且指示验证图像的每个区域有多重要。 然后，可以基于一定的标准从多个权重中舍弃权重。

公开(公告)号：US20090269022A1

公开(公告)日：2009-10-29

申请号：US12109730

申请日：2008-04-25

Applicant: Jianguo Li ,  Tao Wang ,  Yimin Zhang

Inventor： Jianguo Li ,  Tao Wang ,  Yimin Zhang

IPC: H04N5/93

CPC classification number: H04N9/8205

Abstract: A method, apparatus and system for, for each of a plurality of image frames, assigning a pattern number to each of a set of pixel neighborhoods within the frame and assigning a relationship number to each of a plurality of sets of pattern numbers based on a probability of transitioning between different pattern numbers in the set of pattern numbers when transitioning between different pixel neighborhoods. For a subset of the plurality of frames, the subset of frames may be determined to be similar, for example, based on the similarity of the relationship numbers of the subset of the plurality of frames. Other embodiments are described and claimed.

Abstract translation: 一种用于多个图像帧中的每一个的方法，装置和系统，用于将图案编号分配给所述帧内的一组像素邻域中的每一者，并且基于 在不同像素邻域之间转换时，在图案号码集合中的不同图案号之间的转换概率。 对于多个帧的子集，可以例如基于多个帧的子集的关系号的相似性来确定帧的子集类似。 描述和要求保护其他实施例。

公开(公告)号：US20090253741A1

公开(公告)日：2009-10-08

申请号：US12484407

申请日：2009-06-15

Applicant: Tao Wang ,  Ying Han ,  John F. Kadow ,  Zhongxing Zhang ,  Nicholas A. Meanwell

Inventor： Tao Wang ,  Ying Han ,  John F. Kadow ,  Zhongxing Zhang ,  Nicholas A. Meanwell

IPC: A61K31/4709 ,  C07D401/12 ,  A61P31/18

CPC classification number: A61K31/445 ,  A61K31/4545 ,  A61K45/06 ,  C07D211/70 ,  C07D401/06 ,  C07D401/12 ,  C07D401/14 ,  C07D413/06 ,  C07D413/14 ,  A61K2300/00

Abstract: This disclosure provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the disclosure is concerned with alkene piperidine derivatives that possess unique antiviral activity. More particularly, the present disclosure relates to compounds useful for the treatment of HIV and AIDS.

Abstract translation: 本公开提供具有药物和生物影响性质的化合物，其药物组合物和使用方法。 特别地，本公开涉及具有独特抗病毒活性的烯烃哌啶衍生物。 更具体地，本公开涉及可用于治疗HIV和AIDS的化合物。

公开(公告)号：US07598198B2

公开(公告)日：2009-10-06

申请号：US12183247

申请日：2008-07-31

Applicant: Tao Wang ,  Leslie Wade ,  Ioan Nicolau ,  Yumin Liu ,  Victor Wong ,  Barbara Kimmich ,  Jun Han ,  Valery Sokolovskii ,  Alfred Hagemeyer ,  David M. Lowe ,  Karin Yaccato ,  Anthony Volpe

Inventor： Tao Wang ,  Leslie Wade ,  Ioan Nicolau ,  Yumin Liu ,  Victor Wong ,  Barbara Kimmich ,  Jun Han ,  Valery Sokolovskii ,  Alfred Hagemeyer ,  David M. Lowe ,  Karin Yaccato ,  Anthony Volpe

IPC: B01J31/04 ,  B01J37/08 ,  B01J23/40 ,  B01J23/52 ,  B01J23/58 ,  C08F4/603

CPC classification number: B01J23/58 ,  B01J23/464 ,  B01J23/52 ,  B01J33/00 ,  B01J35/002 ,  B01J35/0026 ,  B01J35/008 ,  B01J35/0086 ,  B01J35/026 ,  B01J35/1014 ,  B01J35/1019 ,  B01J35/1042 ,  B01J37/0201 ,  B01J37/0244 ,  B01J37/16 ,  C07C67/055 ,  C07C69/15

Abstract: The present invention addresses at least four different aspects relating to catalyst structure, methods of making those catalysts and methods of using those catalysts for making alkenyl alkanoates. Separately or together in combination, the various aspects of the invention are directed at improving the production of alkenyl alkanoates and VA in particular, including reduction of by-products and improved production efficiency. A first aspect of the present invention pertains to a unique palladium/gold catalyst or pre-catalyst (optionally calcined) that includes rhodium or another metal. A second aspect pertains to a palladium/gold catalyst or pre-catalyst that is based on a layered support material where one layer of the support material is substantially free of catalytic components. A third aspect pertains to a palladium/gold catalyst or pre-catalyst on a zirconia containing support material. A fourth aspect pertains to a palladium/gold catalyst or pre-catalyst that is produced from substantially chloride free catalytic components.

Abstract translation: 本发明涉及与催化剂结构有关的至少四个不同方面，制备这些催化剂的方法和使用这些催化剂制备烯基链烷酸酯的方法。 本发明的单独或一起组合地涉及改进烯基链烷酸酯和VA的生产，特别是包括副产物的还原和提高的生产效率。 本发明的第一方面涉及包含铑或其它金属的独特的钯/金催化剂或预催化剂（任选煅烧的）。 第二方面涉及基于层状载体材料的钯/金催化剂或预催化剂，其中一层载体材料基本上不含催化组分。 第三方面涉及在含氧化锆载体材料上的钯/金催化剂或预催化剂。 第四方面涉及由基本上不含氯的催化组分制备的钯/金催化剂或预催化剂。

公开(公告)号：US20080287285A1

公开(公告)日：2008-11-20

申请号：US12183247

申请日：2008-07-31

Applicant: Tao Wang ,  Les Wade ,  Ioan Nicolau ,  Barbara Kimmich ,  Victor Wong ,  Yumin Liu ,  Jun Han ,  Valery Sokolovskii ,  Alfred Hagemeyer ,  David M. Lowe ,  Anthony Volpe ,  Karin Yaccato

Inventor： Tao Wang ,  Les Wade ,  Ioan Nicolau ,  Barbara Kimmich ,  Victor Wong ,  Yumin Liu ,  Jun Han ,  Valery Sokolovskii ,  Alfred Hagemeyer ,  David M. Lowe ,  Anthony Volpe ,  Karin Yaccato

IPC: B01J31/02

CPC classification number: B01J23/58 ,  B01J23/464 ,  B01J23/52 ,  B01J33/00 ,  B01J35/002 ,  B01J35/0026 ,  B01J35/008 ,  B01J35/0086 ,  B01J35/026 ,  B01J35/1014 ,  B01J35/1019 ,  B01J35/1042 ,  B01J37/0201 ,  B01J37/0244 ,  B01J37/16 ,  C07C67/055 ,  C07C69/15

Abstract: The present invention addresses at least four different aspects relating to catalyst structure, methods of making those catalysts and methods of using those catalysts for making alkenyl alkanoates. Separately or together in combination, the various aspects of the invention are directed at improving the production of alkenyl alkanoates and VA in particular, including reduction of by-products and improved production efficiency. A first aspect of the present invention pertains to a unique palladium/gold catalyst or pre-catalyst (optionally calcined) that includes rhodium or another metal. A second aspect pertains to a palladium/gold catalyst or pre-catalyst that is based on a layered support material where one layer of the support material is substantially free of catalytic components. A third aspect pertains to a palladium/gold catalyst or pre-catalyst on a zirconia containing support material. A fourth aspect pertains to a palladium/gold catalyst or pre-catalyst that is produced from substantially chloride free catalytic components.

Abstract translation: 本发明涉及与催化剂结构有关的至少四个不同方面，制备这些催化剂的方法和使用这些催化剂制备烯基链烷酸酯的方法。 本发明的单独或一起组合地涉及改进烯基链烷酸酯和VA的生产，特别是包括副产物的还原和提高的生产效率。 本发明的第一方面涉及包含铑或其它金属的独特的钯/金催化剂或预催化剂（任选煅烧的）。 第二方面涉及基于层状载体材料的钯/金催化剂或预催化剂，其中一层载体材料基本上不含催化组分。 第三方面涉及在含氧化锆载体材料上的钯/金催化剂或预催化剂。 第四方面涉及由基本上不含氯的催化组分制备的钯/金催化剂或预催化剂。

公开(公告)号：US20080194606A1

公开(公告)日：2008-08-14

申请号：US11913451

申请日：2006-05-04

Applicant: David Scott ,  Haixia Wang ,  Tao Wang

Inventor： David Scott ,  Haixia Wang ,  Tao Wang

IPC: A61K31/506 ,  C07D403/12 ,  A61P35/04

CPC classification number: C07D403/12

Abstract: This invention relates to novel compounds having the formula (I), and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.

Abstract translation: 本发明涉及具有式（I）的新化合物及其药物组合物及其使用方法。 这些新型化合物为癌症提供治疗。

公开(公告)号：US07354924B2

公开(公告)日：2008-04-08

申请号：US10969675

申请日：2004-10-20

Applicant: Tao Wang ,  Zhongxing Zhang ,  Nicholas A. Meanwell ,  John F. Kadow ,  Zhiwei Yin ,  Qiufen May Xue ,  Alicia Regueiro-Ren ,  John D. Matiskella ,  Yasutsugu Ueda

Inventor： Tao Wang ,  Zhongxing Zhang ,  Nicholas A. Meanwell ,  John F. Kadow ,  Zhiwei Yin ,  Qiufen May Xue ,  Alicia Regueiro-Ren ,  John D. Matiskella ,  Yasutsugu Ueda

IPC: A61K31/496 ,  C07D487/02 ,  A61K31/497 ,  A61K31/501 ,  A61K31/506

CPC classification number: C07D471/04 ,  A61K31/496 ,  A61K45/06 ,  C07D491/048

Abstract: This invention provides Compounds I having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS. Compound I is wherein: Q is selected from the group consisting of: m is 1 or 2; —W— is A is selected from the group consisting of C1-6alkoxy, aryl and heteroaryl; in which said aryl is phenyl or napthyl; said heteroaryl is selected from the group consisting of pyridinyl, pyrimidinyl, pyrazinyl, triazinyl, furanyl, thienyl, pyrrolyl, imidazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, quinolinyl, isoquinolinyl, benzofuranyl, benzothienyl, benzoimidazolyl and benzothiazolyl; and said aryl or heteroaryl is optionally substituted with one or two of the same or different members selected from the group consisting of amino, nitro, cyano, hydroxy, C1-6alkoxy, —C(O)NH2; and C1-6alkyl, —NHC(O)CH3, halogen and trifluoromethyl.

Abstract translation: 本发明提供具有药物和生物影响性质的化合物I，其药物组合物和使用方法。 特别地，本发明涉及氮杂吲哚乙酰基哌嗪衍生物。 这些化合物具有独特的抗病毒活性，无论是单独使用还是与其他抗病毒药，抗感染剂，免疫调节剂或HIV进入抑制剂组合使用。 更具体地说，本发明涉及艾滋病毒和艾滋病的治疗。 化合物I是其中：Q选自：m是1或2; -W-是A选自C 1-6烷氧基，芳基和杂芳基; 其中所述芳基是苯基或萘基; 吡啶基，吡嗪基，咪唑基，噻唑基，异噻唑基，恶唑基，异恶唑基，喹啉基，异喹啉基，苯并呋喃基，苯并噻吩基，苯并咪唑基和苯并噻唑基; 并且所述芳基或杂芳基任选被一个或两个相同或不同的选自氨基，硝基，氰基，羟基，C 1-6烷氧基，-C（O） NH 2; 和C 1-6烷基，-NHC（O）CH 3，卤素和三氟甲基。